Cargando…
Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension
BACKGROUND: Recently, we and others have reported a causal role for oxidized lipids in the pathogenesis of pulmonary hypertension (PH). However, the role of low‐density lipoprotein receptor (LDL‐R) in PH is not known. METHODS AND RESULTS: We examined the role of LDL‐R in the development of PH and de...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033825/ https://www.ncbi.nlm.nih.gov/pubmed/31914876 http://dx.doi.org/10.1161/JAHA.119.012063 |
_version_ | 1783499748485890048 |
---|---|
author | Umar, Soban Ruffenach, Gregoire Moazeni, Shayan Vaillancourt, Mylene Hong, Jason Cunningham, Christine Cao, Nancy Navab, Sara Sarji, Shervin Li, Min Lee, Lisa Fishbein, Greg Ardehali, Abbas Navab, Mohamad Reddy, Srinivasa T. Eghbali, Mansoureh |
author_facet | Umar, Soban Ruffenach, Gregoire Moazeni, Shayan Vaillancourt, Mylene Hong, Jason Cunningham, Christine Cao, Nancy Navab, Sara Sarji, Shervin Li, Min Lee, Lisa Fishbein, Greg Ardehali, Abbas Navab, Mohamad Reddy, Srinivasa T. Eghbali, Mansoureh |
author_sort | Umar, Soban |
collection | PubMed |
description | BACKGROUND: Recently, we and others have reported a causal role for oxidized lipids in the pathogenesis of pulmonary hypertension (PH). However, the role of low‐density lipoprotein receptor (LDL‐R) in PH is not known. METHODS AND RESULTS: We examined the role of LDL‐R in the development of PH and determined the efficacy of high‐density lipoprotein mimetic peptide 4F in mitigating PH. Explanted human lungs and plasma from patients with PH and control subjects were analyzed for gene expression, histological characteristics, and lipoprotein oxidation. Male LDL‐R null (LDL‐R knockout) mice (12–15 months old) were fed chow, Western diet (WD), WD with 4F, and WD with scramble peptide for 12 weeks. Serial echocardiography, cardiac catheterization, oxidized LDL assay, real‐time quantitative reverse transcription–polymerase chain reaction, and histological analysis were performed. The effect of LDL‐R knockdown and oxidized LDL on human pulmonary artery smooth muscle cell proliferation was assessed in vitro. LDL‐R and CD36 expression levels were significantly downregulated in the lungs of patients with PH. Patients with PH also had increased lung lipid deposits, oxidized LDL, E06 immunoreactivity, and plasma oxidized LDL/LDL ratio. LDL‐R knockout mice on WD developed PH, right ventricular hypertrophy, right ventricular dysfunction, pulmonary vascular remodeling, fibrosis, and lipid deposition in lungs, aortic atherosclerosis, and left ventricular dysfunction, which were prevented by 4F. Interestingly, PH in WD group preceded left ventricular dysfunction. Oxidized LDL or LDL‐R knockdown significantly increased proliferation of human pulmonary artery smooth muscle cells in vitro. CONCLUSIONS: Human PH is associated with decreased LDL‐R in lungs and increased oxidized LDL in lungs and plasma. WD‐fed LDL‐R knockout mice develop PH and right ventricular dysfunction, implicating a role for LDL‐R and oxidized lipids in PH. |
format | Online Article Text |
id | pubmed-7033825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70338252020-02-27 Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension Umar, Soban Ruffenach, Gregoire Moazeni, Shayan Vaillancourt, Mylene Hong, Jason Cunningham, Christine Cao, Nancy Navab, Sara Sarji, Shervin Li, Min Lee, Lisa Fishbein, Greg Ardehali, Abbas Navab, Mohamad Reddy, Srinivasa T. Eghbali, Mansoureh J Am Heart Assoc Original Research BACKGROUND: Recently, we and others have reported a causal role for oxidized lipids in the pathogenesis of pulmonary hypertension (PH). However, the role of low‐density lipoprotein receptor (LDL‐R) in PH is not known. METHODS AND RESULTS: We examined the role of LDL‐R in the development of PH and determined the efficacy of high‐density lipoprotein mimetic peptide 4F in mitigating PH. Explanted human lungs and plasma from patients with PH and control subjects were analyzed for gene expression, histological characteristics, and lipoprotein oxidation. Male LDL‐R null (LDL‐R knockout) mice (12–15 months old) were fed chow, Western diet (WD), WD with 4F, and WD with scramble peptide for 12 weeks. Serial echocardiography, cardiac catheterization, oxidized LDL assay, real‐time quantitative reverse transcription–polymerase chain reaction, and histological analysis were performed. The effect of LDL‐R knockdown and oxidized LDL on human pulmonary artery smooth muscle cell proliferation was assessed in vitro. LDL‐R and CD36 expression levels were significantly downregulated in the lungs of patients with PH. Patients with PH also had increased lung lipid deposits, oxidized LDL, E06 immunoreactivity, and plasma oxidized LDL/LDL ratio. LDL‐R knockout mice on WD developed PH, right ventricular hypertrophy, right ventricular dysfunction, pulmonary vascular remodeling, fibrosis, and lipid deposition in lungs, aortic atherosclerosis, and left ventricular dysfunction, which were prevented by 4F. Interestingly, PH in WD group preceded left ventricular dysfunction. Oxidized LDL or LDL‐R knockdown significantly increased proliferation of human pulmonary artery smooth muscle cells in vitro. CONCLUSIONS: Human PH is associated with decreased LDL‐R in lungs and increased oxidized LDL in lungs and plasma. WD‐fed LDL‐R knockout mice develop PH and right ventricular dysfunction, implicating a role for LDL‐R and oxidized lipids in PH. John Wiley and Sons Inc. 2020-01-09 /pmc/articles/PMC7033825/ /pubmed/31914876 http://dx.doi.org/10.1161/JAHA.119.012063 Text en © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Umar, Soban Ruffenach, Gregoire Moazeni, Shayan Vaillancourt, Mylene Hong, Jason Cunningham, Christine Cao, Nancy Navab, Sara Sarji, Shervin Li, Min Lee, Lisa Fishbein, Greg Ardehali, Abbas Navab, Mohamad Reddy, Srinivasa T. Eghbali, Mansoureh Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension |
title | Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension |
title_full | Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension |
title_fullStr | Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension |
title_full_unstemmed | Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension |
title_short | Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension |
title_sort | involvement of low‐density lipoprotein receptor in the pathogenesis of pulmonary hypertension |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033825/ https://www.ncbi.nlm.nih.gov/pubmed/31914876 http://dx.doi.org/10.1161/JAHA.119.012063 |
work_keys_str_mv | AT umarsoban involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT ruffenachgregoire involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT moazenishayan involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT vaillancourtmylene involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT hongjason involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT cunninghamchristine involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT caonancy involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT navabsara involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT sarjishervin involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT limin involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT leelisa involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT fishbeingreg involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT ardehaliabbas involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT navabmohamad involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT reddysrinivasat involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension AT eghbalimansoureh involvementoflowdensitylipoproteinreceptorinthepathogenesisofpulmonaryhypertension |